Mon panier

resDetect™ Human Tumor Necrosis Factor Alpha (TNF-α) ELISA Kit (Residue Testing)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
RES-A027-96tests
$550.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Product Specifications

    Assay Type
    Sandwich-ELISA
    Analyte
    TNF-α
    Format
    96T (8×12 strips)
    Reactivity
    Human
    Regulatory Status
    RUO
    Sensitivity
    < 6.25 pg/mL
    Standard Curve Range
    6.25-400 pg/mL
    Assay Time
    2 hr 50 min
    Suitable Sample Type
    For the quantitative determination of human TNF-α in Cell Culture Supernatants, Plasma, Serum.
    Sample volume
    100 μL

  • Product Overview

    Human Tumor Necrosis Factor Alpha (TNF-α) ELISA Kit (Residue Testing) is based on the ELISA sandwich method and is used to detect and quantitatively determine GMP human TNF-α residues in cell culture supernatants, serum, and plasma. The kit contains GMP human Tumor Necrosis Factor Alpha (TNF-α) (ACROBiosystems, cat# GMP-TNAH23) to ensure accurate assay results and is designed to provide a reliable solution for CAR-T product quality assessment during drug development and CMC quality control stages. It can also be used as a universal detection tool for the quantitative determination of TNF-α.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    RES027-C01
    Pre-coated Anti-TNF-α Antibody Microplate
    1 plate (8×12 strips)
    RES027-C02
    Human TNF-α Standard
    15 μg
    RES027-C03
    Biotin-Anti-TNF-α Antibody
    20 μg
    RES027-C04
    Streptavidin-HRP
    50 μL
    RES027-C05
    10xWashing Buffer
    50 mL
    RES027-C06
    2xDilution Buffer
    50 mL
    RES027-C07
    Substrate Solution
    12 mL
    RES027-C08
    Stop Solution
    7 mL

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Typical Data 

    Please refer to DS document for the assay protocol.

     TNF-alpha TYPICAL DATA

    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

Validation
  • Dilution Linearity

    To assess the linearity of the assay, samples spiked with high concentrations of human TNF-α, were serially diluted with calibrator diluent to produce samples with values within the dynamic range of the assay.

     TNF-alpha DILUTION LINEARITY
  • Intra-Assay Statistics

    Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision, Intra-Assay Precision CV<10%.

     TNF-alpha INTRA-ASSAY STATISTICS
  • Inter-Assay Statistics

    Three samples of known concentration were tested in three separate assays to assess inter-assay precision, Inter-Assay Precision CV<10%.

     TNF-alpha INTER-ASSAY STATISTICS
  • Recovery

    Three parts of blank serum were added with different concentrations of human TNF-α, and the serum without human TNF-α was used as background to calculate the recovery rate. The range of the recovery rate is 89.2-116.0%, and the average recovery is 98.3%.

     TNF-alpha RECOVERY

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Tumor necrosis factor α

  • Catégorie:

  • Nombre de médicaments répertoriés:

    68 Détails

  • Nombre de médicaments cliniques:

    74 Détails

  • Étape de développement la plus élevée:

    Approved

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs